M.J. Main
Molecular Pharmacology
Neuroscience
Glaxo-Wellcome Research & Development
Stevenage
United Kingdom
Name/email consistency: high
- Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. Main, M.J., Cryan, J.E., Dupere, J.R., Cox, B., Clare, J.J., Burbidge, S.A. Mol. Pharmacol. (2000)









